Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease

被引:1
作者
Chaudhary, Rishabh [1 ,2 ]
Singh, Randhir [1 ]
机构
[1] Cent Univ Punjab, Dept Pharmacol, Bathinda 151401, India
[2] Maharishi Markandeshwar, MM Coll Pharm, Dept Pharmacol, Ambala 133207, Haryana, India
关键词
Parkinson's disease; locomotion abnormalities; animal models; neurobiological indicators; therapeutic options; neurotoxin; 6-hydroxydopamine; pedunculopontine nucleus; alpha-synuclein; DOPA-INDUCED DYSKINESIA; NIGRA PARS COMPACTA; DEEP BRAIN-STIMULATION; INTRASTRIATAL 6-HYDROXYDOPAMINE MODEL; ALTERED NEURONAL-ACTIVITY; MEDIAL PREFRONTAL CORTEX; REDUCES OXIDATIVE STRESS; PARKINSONS-DISEASE; ANIMAL-MODELS; PEDUNCULOPONTINE NUCLEUS;
D O I
10.2174/1871527322666230518111323
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Locomotion problems in Parkinson's syndrome are still a research and treatment difficulty. With the recent introduction of brain stimulation or neuromodulation equipment that is sufficient to monitor activity in the brain using electrodes placed on the scalp, new locomotion investigations in patients having the capacity to move freely have sprung up.Objective This study aimed to find rat models and locomotion-connected neuronal indicators and use them all over a closed-loop system to enhance the future and present treatment options available for Parkinson's disease.Methods Various publications on locomotor abnormalities, Parkinson's disease, animal models, and other topics have been searched using several search engines, such as Google Scholar, Web of Science, Research Gate, and PubMed.Results Based on the literature, we can conclude that animal models are used for further investigating the locomotion connectivity deficiencies of many biological measuring devices and attempting to address unanswered concerns from clinical and non-clinical research. However, translational validity is required for rat models to contribute to the improvement of upcoming neurostimulation-based medicines. This review discusses the most successful methods for modelling Parkinson's locomotion in rats.Conclusion This review article has examined how scientific clinical experiments lead to localised central nervous system injuries in rats, as well as how the associated motor deficits and connection oscillations reflect this. This evolutionary process of therapeutic interventions may help to improve locomotion-based treatment and management of Parkinson's syndrome in the upcoming years.
引用
收藏
页码:488 / 503
页数:16
相关论文
共 168 条
[1]   Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations [J].
Abdelkader, Noha F. ;
Safar, Marwa M. ;
Salem, Hesham A. .
MOLECULAR NEUROBIOLOGY, 2016, 53 (02) :810-817
[2]   Intrinsic Disruption of the M1 Cortical Network in a Mouse Model of Parkinson's Disease [J].
Aeed, Fadi ;
Cermak, Nathan ;
Schiller, Jackie ;
Schiller, Yitzhak .
MOVEMENT DISORDERS, 2021, 36 (07) :1565-1577
[3]   Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease [J].
Ahn, Sora ;
Song, Taek-Jin ;
Park, Seong-Uk ;
Jeon, Songhee ;
Kim, Jongpil ;
Oh, Joo-Young ;
Jang, Jaehwan ;
Hong, Sanhwa ;
Song, Min-A ;
Shin, Hye-Seoung ;
Jung, Young-Rim ;
Park, Hi-Joon .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
[4]   Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease [J].
Aravamuthan, Bhooma R. ;
Bergstrom, Debra A. ;
French, Robin A. ;
Taylor, Joseph J. ;
Parr-Brownlie, Louise C. ;
Walters, Judith R. .
EXPERIMENTAL NEUROLOGY, 2008, 213 (02) :268-280
[5]   Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats [J].
Aristieta, A. ;
Ruiz-Ortega, J. A. ;
Miguelez, C. ;
Morera-Herreras, T. ;
Ugedo, L. .
NEUROBIOLOGY OF DISEASE, 2016, 89 :88-100
[6]   Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat [J].
Avila, Irene ;
Parr-Brownlie, Louise C. ;
Brazhnik, Elena ;
Castaneda, Edward ;
Bergstrom, Debra A. ;
Walters, Judith R. .
EXPERIMENTAL NEUROLOGY, 2010, 221 (02) :307-319
[7]   Neuroprotective Effect of Genistein in 6-Hydroxydopamine Hemi-parkinsonian Rat Model [J].
Baluchnejadmojarad, Tourandokht ;
Roghani, Mehrdad ;
Nadoushan, Mohammad Reza Jalalli ;
Bagheri, Maryam .
PHYTOTHERAPY RESEARCH, 2009, 23 (01) :132-135
[8]  
BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600
[9]   Animal models of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
Greenamyre, JT .
BIOESSAYS, 2002, 24 (04) :308-318
[10]   Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies [J].
Bezard, Erwan ;
Yue, Zhenyu ;
Kirik, Deniz ;
Spillantini, Maria Grazia .
MOVEMENT DISORDERS, 2013, 28 (01) :61-70